Boston Scientific Corp. (NYSE: BSX) Has Another Chance To Impress You
Currently, there are 1.46B common shares owned by the public and among those 1.46B shares have been available to trade. Insiders at the company have transacted a total of 106 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 58 of these insider trades were purchases, […]
Value Hunters: Look To Boston Scientific Corp. (BSX)
Currently, there are 1.46B common shares owned by the public and among those 1.46B shares have been available to trade. Insiders at the company have transacted a total of 190 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 98 of these insider trades were purchases, […]
Boston Scientific Corp. (NYSE: BSX) Seen Running Too Hot, Let’s Look At This More Closely
Currently, there are 1.46B common shares owned by the public and among those 1.46B shares have been available to trade. Insiders at the company have transacted a total of 195 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 99 of these insider trades were purchases, […]
Boston Scientific Corp. (BSX): A Great Stock For Handling Current Market Conditions?
The Vanguard Group, Inc. recently announced the acquisition of new stake in Boston Scientific Corp. (NYSE:BSX). The institutional investor has increased its shareholding in the Healthcare company by 1.20% to 117.78 million shares with purchase of 1.4 million shares. This fresh investment now brings its stake to 8.04% valued currently at $6.81 billion. In addition, […]
Boston Scientific Corp. (NYSE: BSX): Hunting Genuine Value In Market Debris
The Vanguard Group, Inc. recently announced the acquisition of new stake in Boston Scientific Corp. (NYSE:BSX). The institutional investor has increased its shareholding in the Healthcare company by 1.20% to 117.78 million shares with purchase of 1.4 million shares. This fresh investment now brings its stake to 8.04% valued currently at $6.81 billion. In addition, […]
Boston Scientific Corp. (NYSE: BSX): Hunting Genuine Value In Market Debris
The Vanguard Group, Inc. recently announced the acquisition of new stake in Boston Scientific Corp. (NYSE:BSX). The institutional investor has increased its shareholding in the Healthcare company by 1.20% to 117.78 million shares with purchase of 1.4 million shares. This fresh investment now brings its stake to 8.04% valued currently at $6.58 billion. In addition, […]
Reassessing The Changing Outlook For Boston Scientific Corp. (BSX)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Boston Scientific Corp. (NYSE:BSX). The institutional investor has increased its shareholding in the Healthcare company by 1.20% to 117.78 million shares with purchase of 1.4 million shares. This fresh investment now brings its stake to 8.04% valued currently at $6.58 billion. In addition, […]
Analysts Update Their Price Forecasts For Boston Scientific Corp. (BSX)
The Vanguard Group, Inc. has recently announced that it has increased stake in Boston Scientific Corp. (NYSE:BSX) by 1.20%. After grabbing 117.78 million shares, the institutional investor is now in possession of 1.4 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 8.04% having worth around $6.58 billion. […]
Boston Scientific Corp. (BSX): A Great Stock For Handling Current Market Conditions?
The Vanguard Group, Inc. recently announced the acquisition of new stake in Boston Scientific Corp. (NYSE:BSX). The institutional investor has increased its shareholding in the Healthcare company by 1.20% to 117.78 million shares with purchase of 1.4 million shares. This fresh investment now brings its stake to 8.04% valued currently at $6.58 billion. In addition, […]
Stick With Boston Scientific Corp. (BSX). The Bull Are Alive And Well
The Vanguard Group, Inc. recently announced the acquisition of new stake in Boston Scientific Corp. (NYSE:BSX). The institutional investor has increased its shareholding in the Healthcare company by 1.20% to 117.78 million shares with purchase of 1.4 million shares. This fresh investment now brings its stake to 8.04% valued currently at $6.03 billion. In addition, […]
